Phase 1 Influenza, Human Clinical Trials

4 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–4 of 4 trials

Recruiting

Phase 1Phase 2

Clinical Trials of Quadrivalent Influenza Vaccine

Influenza, Human

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.620 enrolled1 locationNCT06824519

Recruiting

Phase 1

A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults

Influenza, Human+COVID-19

GlaxoSmithKline225 enrolled2 locationsNCT07464314

Recruiting

Phase 1

Covid-19 and Influenza Oral Vaccine Study

Influenza, Humancovid19 Infection

Vaxine Pty Ltd100 enrolled1 locationNCT06355232

Recruiting

Phase 1Phase 2

Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)

SARS CoV-2Respiratory distress syndromeInfluenza, Human+1 more

PEACHES BIOTECH50 enrolled1 locationNCT06684379